J Korean Foot Ankle Soc.  2024 Sep;28(3):81-86. 10.14193/jkfas.2024.28.3.81.

IFFAS (International Federation of Foot & Ankle Societies) 2024 Conference Report

• Kim J
• Won SH
• Yoon YK
• Park JY

• KMID: 2559636
• DOI: http://doi.org/10.14193/jkfas.2024.28.3.81

Abstract

The International Federation of Foot and Ankle Societies (IFFAS) is a global organization for foot and ankle societies, comprising the Asian Federation of Foot and Ankle Surgeons (AFFAS), the European Foot and Ankle Society (EFAS), the Latin American Federation of Medicine and Surgery of the Foot and Leg (FLAMECIPP), the North American Federation of Foot and Ankle Societies (NAFFAS), and the Southern Federation of Foot and Ankle Society. Since 2005, IFFAS has organized worldwide conferences every three years, starting in Naples, Italy. The 2020 conference in Chile was postponed to 2022 due to COVID-19 pandemic and became biennial with the founding of the Southern Federation. Consequently, the conference is set to take place in Seoul in 2024. IFFAS 2024 was the first global foot and ankle conference held post-pandemic and significant as the first IFFAS event in Asia since the 2011 conference was canceled because of the Great East Japan Earthquake. Under the theme “Meet the knowledge and beautifulness,” the event was hosted in Seoul. The academic program included an AFFAS-hosted event on May 30, followed by the IFFAS-hosted conference from May 31 to June 1, with all events organized by the Korean Foot & Ankle Society (KFAS).

Keyword

Conference & Congresses; Internationality; Foot; Ankle

Figure

• 

  Figure 1 Stance phase of gait was simulated on a 6-degree of freedom robot. Motion capture cameras were used to track the motion of reflective markers attached to the bones of the foot. Reused from the article of Conti et al. (paper presented at: the IFFAS 2024)2) with original copyright holder's permission.

• 

  Figure 2 Bias-corrected 95% confidence intervals of the repeated measures difference in talonavicular kinematics. The asterisk denotes significant differences between the peroneus brevis to longus tendon transfer (PB-to-PL) and simulated progressive collapsing foot deformity (sPCFD) conditions. Reused from the article of Conti et al. (paper presented at: the IFFAS 2024)2) with original copyright holder’s permission.

• 

  Figure 3 Histological analysis by H&E staining (first row, 2×; second row, 10×; third row, 40×) on rat tibia bone fractures at day-90 post-operation shows that the fractured tibia bone in the rats without treatment healed much slower than the other three groups. The fractured bone in the rats with met-IP injection healed much better than the wound only. Met-IP injection inhibited the cell migration induced by frHMGB1 local injection, and improved bone fracture healing. Met-IP: metformin IP; frHMGB1: fully reduced high mobility group box 1. Reused from the article of Cain et al. (paper presented at: the IFFAS 2024)6) with original copyright holder’s permission.

Reference

1. Hansen ST. 2000. Functional reconstruction of the foot and ankle. Lippincott Williams & Wilkins;Philadelphia:

2. Conti MS, Kim J, Hoffman J, Ellis S, Deland J, Steineman B. Joint kinematics after peroneus brevis to longus transfer for treatment of progressive collapsing foot deformity. Paper presented at: the IFFAS 2024; 2024 May 30-Jun 1; Seoul, Korea.

3. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. IOF Bone and Diabetes Working Group. 2017; Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 13:208–19. doi: 10.1038/nrendo.2016.153. DOI: 10.1038/nrendo.2016.153. PMID: 27658727.

4. Arteaga A, Biguetti CC, Chandrashekar B, La Fontaine J, Rodrigues DC. 2023; Revolutionizing fracture fixation in diabetic and non-diabetic rats: high mobility group box 1-based coating for enhanced osseointegration. Bone. 177:116917. doi: 10.1016/j.bone.2023.116917. DOI: 10.1016/j.bone.2023.116917. PMID: 37739297. PMCID: PMC11292581.

5. Skandalis K, Spirova M, Gaitanis G, Tsartsarakis A, Bassukas ID. 2012; Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dermatol Venereol. 26:249–53. doi: 10.1111/j.1468-3083.2011.04062.x. DOI: 10.1111/j.1468-3083.2011.04062.x. PMID: 21466592.

6. Cain JD, Zhang J, Shimazaki K, Brown R, Hogan MV, Wang JHC. Fully-reduced HMGB1 with metformin improves nonunion bone fracture healing in diabetic rats. Paper presented at: the IFFAS 2024; 2024 May 30-Jun 1; Seoul, Korea.